In elderly subjects and patients with end-stage renal disease (ESRD), carotid pulse pressure (PP) is an independent and significant predictor of cardiovascular (CV) risk. Whereas in the elderly carotid diameter, but not carotid stiffness, is an associated CV risk factor, an opposite CV risk pattern was observed in ESRD patients that was associated with stiffness. Whether in ESRD patients arterial diameter, stiffness or both are involved in the mechanism(s) of increased carotid PP has never been investigated. Nondiabetic ESRD patients (n = 144) were compared with 57 control subjects matched for age, sex and mean blood pressure, but with higher brachial and carotid PP. Noninvasive echo-Doppler techniques and pulse wave velocity (PWV) and pulse wave analysis were used to evaluate cardiac and carotid arterial structures and functions using multiple stepwise regressions. In controls, carotid PP was associated only with stroke volume, arterial wave reflections and aortic PWV, but not aortic diameter. In ESRD patients, it was associated with wave reflections, aortic PWV, stroke volume and higher aortic diameter. In ESRD patients and controls, elevated carotid PP mainly reflected increased aortic PWV and earlier wave reflections. Aortic diameter had an impact only on ESRD patients, where it compensated for enhanced aortic stiffness and the more pronounced effect of reflected waves. This hemodynamic profile differs consistently from that in elderly subjects of the general population and selectively influences CV risk and drug treatment.

Keywords:
Carotid artery, Pulse pressure, Arterial stiffness, Wave reflections, Aortic diameter, Characteristic impedance, End-stage renal disease
1.
Franklin SS, Wilkinson JB, Cockroft JR: Brachial and central pulse pressure, and cardiovascular risk; in Safar ME, O’Rourke MF (eds): Arterial Stiffness in Hypertension. Edinburgh, Elsevier, 2006, pp 225–224.
2.
Safar ME, Blacher J, Pannier B, Guérin AP, Marchais SJ, Guyonvarc’h PM, London GM: Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002;39:735–738.
3.
Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM: Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998;32:570–574.
4.
Izzo JL, Mitchell GF: Aging and arterial structure-function relations; in Safar ME, Frohlich ED (eds): Atherosclerosis, Large Arteries and Cardiovascular Risk. Adv Cardiol. Basel, Karger, 2007, vol 44, pp 19–34.
5.
London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F: Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996;50:600–608.
6.
London GM, Cohn JN: Prognostic application of arterial stiffness: task forces. Am J Hypertens 2002;15:754–758.
7.
Smulyan H, Siddiqui DS, Carlson RJ, London GM, Safar ME: Clinical utility of aortic pulses and pressures calculated from applanated radial-artery pulses. Hypertension 2003;42:150–155.
8.
Nichols WW, O’Rourke MF: Wave reflection; in Nichols WW, O’Rourke MF: McDonald’s Blood Flow in the Arteries, ed 5. London, Hodder Arnold Publishers, 2005, pp 195–211.
9.
Mitchell GF, Lacourciere Y, Ouellet JP, Izzo JL Jr, Neutel J, Kerwin LJ, Block AJ, Pfeffer MA: Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationship. Circulation 2003;108:1592–1598.
10.
Farasat SM, Morrell CH, Scuteri A, Ting CT, Yin FC, Spurgeon HA, Chen CH, Lakatta EG, Najjar SS: Pulse pressure is inversely related to aortic root diameter implications for the pathogenesis of systolic hypertension. Hypertension 2008;51:196–202.
11.
Ingelsson E, Pencina MJ, Levy D, Aragam J, Mitchell GF, Benjamin EJ, Varsan RS: Aortic root diameter and longitudinal blood pressure tracking. Hypertension 2008;52:473–477.
12.
Dijk JM, Algra A, van der Graaf Y, Grobbee DE, Bots ML: Carotid stiffness and the risk of new vascular events in patients with manifest cardiovascular disease. The SMART study. Eur Heart J 2005;26:1213–1220.
13.
Leone N, Ducimetiere P, Gariepy J, Courbon D, Tzourio C, Dartigues JF, Ritchie K, Alperovitch A, Amouyel P, Safar ME, Zureik M: Distension of the carotid artery and risk of coronary events: the three-city study. Arterioscler Thromb Vasc Biol 2008;28:1392–1397.
14.
Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, Witteman JC: Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006;113:657–663.
15.
Stork S, van den Beld AW, von Schacky C, Angermann CE, Lamberts SW, Grobbee DE, Bots ML: Carotid artery plaque burden, stiffness, and mortality risk in elderly men: a prospective, population-based cohort study. Circulation 2004;110:344–348.
16.
Pannier B, Guérin AP, Marchais SJ, Métivier F, London GM: Arterial stricture and function in end-stage renal disease. Artery Res 2007;1:79–88.
17.
London GM, Marchais SJ, Guerin AP, Boutouyrie P, Metivier F, de Vernejoul MC: Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 2008;19:1827–1835.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.